Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant
Public ClinicalTrials.gov record NCT02988115. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180 mg Compared to Placebo Added to Background Lipid-Modifying Therapy in Patients With Elevated LDL-C Who Are Statin Intolerant
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if bempedoic acid (ETC-1002) is effective and safe versus placebo in patients with elevated LDL cholesterol and who are statin-intolerant.
Study identification
- NCT ID
- NCT02988115
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 345 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 16, 2016 (Actual)
- Primary completion
- Mar 16, 2018 (Actual)
- Completion
- Mar 16, 2018 (Actual)
- Last update posted
- Apr 3, 2020
2016 – 2018
United States locations
- U.S. sites
- 52
- U.S. states
- 25
- U.S. cities
- 50
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Gilbert | Arizona | — | — |
| Not listed | Anaheim | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | Santa Ana | California | — | — |
| Not listed | Torrance | California | — | — |
| Not listed | Ventura | California | — | — |
| Not listed | Hamden | Connecticut | — | — |
| Not listed | Daytona Beach | Florida | — | — |
| Not listed | Fort Lauderdale | Florida | — | — |
| Site 1 | Miami | Florida | — | — |
| Site 2 | Miami | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | West Palm Beach | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Savannah | Georgia | — | — |
| Not listed | Meridian | Idaho | — | — |
| Not listed | Evanston | Illinois | — | — |
| Not listed | Evansville | Indiana | — | — |
| Not listed | Iowa City | Iowa | — | — |
| Not listed | Waterloo | Iowa | — | — |
| Not listed | Monroe | Louisiana | — | — |
| Not listed | Slidell | Louisiana | — | — |
| Not listed | Tupelo | Mississippi | — | — |
| Not listed | Lincoln | Nebraska | — | — |
| Not listed | Somerset | New Jersey | — | — |
| Not listed | Binghamton | New York | — | — |
| Not listed | Endwell | New York | — | — |
| Not listed | New Windsor | New York | — | — |
| Not listed | Greensboro | North Carolina | — | — |
| Not listed | Morganton | North Carolina | — | — |
| Not listed | Mount Airy | North Carolina | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Marion | Ohio | — | — |
| Not listed | Maumee | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Beaver | Pennsylvania | — | — |
| Not listed | Langhorne | Pennsylvania | — | — |
| Not listed | Cumberland | Rhode Island | — | — |
| Not listed | Anderson | South Carolina | — | — |
| Not listed | Summerville | South Carolina | — | — |
| Not listed | Jackson | Tennessee | — | — |
| Not listed | Knoxville | Tennessee | — | — |
| Not listed | Memphis | Tennessee | — | — |
| Not listed | Amarillo | Texas | — | — |
| Site 1 | Dallas | Texas | — | — |
| Site 2 | Dallas | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Clinton | Utah | — | — |
| Not listed | Hampton | Virginia | — | — |
| Not listed | Kenosha | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02988115, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 3, 2020 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02988115 live on ClinicalTrials.gov.